share_log

CytoSorbents Q1 2024 GAAP EPS $(0.12), Inline, Sales $9.787M Beat $9.785M Estimate

Benzinga ·  May 9 17:19

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 29.41 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $9.787 million which beat the analyst consensus estimate of $9.785 million by 0.02 percent. This is a 3.58 percent increase over sales of $9.449 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment